Concepción Vicenta Llorente Cortés

Title: Concepción Vicenta Llorente Cortés: Innovator in Cardiovascular Research

Introduction

Concepción Vicenta Llorente Cortés is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of cardiovascular research, particularly in understanding cholesterol metabolism during ischaemic conditions. His work has implications for treating and preventing heart-related diseases.

Latest Patents

Llorente Cortés holds a patent titled "LRP1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (VLDL) to ischaemic cardiac muscle." This invention focuses on novel molecules that can modulate mechanisms leading to cholesterol deposition in cardiomyocytes and smooth muscle cells during acute myocardial infarction. The patent highlights that blocking LRP1 using various agents can prevent the overaccumulation of esterified cholesterol in these cells exposed to ischaemia. Additionally, the invention relates to the use of these molecules in treating and preventing changes in calcium metabolism and cardiac remodeling associated with ischaemia.

Career Highlights

Throughout his career, Llorente Cortés has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas and the Instituto Catalán de Ciencias Cardiovasculares. His research has been pivotal in advancing the understanding of cardiovascular health and disease.

Collaborations

Llorente Cortés has collaborated with notable professionals in his field, including Lina Badimon Maestro. Their joint efforts have contributed to significant advancements in cardiovascular research.

Conclusion

Concepción Vicenta Llorente Cortés is a distinguished inventor whose work in cardiovascular research has the potential to impact the treatment of heart diseases significantly. His innovative approaches to cholesterol metabolism during ischaemia highlight the importance of continued research in this critical area of health.